Irish approvals process delays mean public patients forced to wait for new therapies already available to private patients
Oliver O'Connor
Ireland has delivered on creating pharma clusters but needs to focus more on innovation and next generation medicines, says Ipha
Waiving patent rights may have chilling effect on medicine development, industry warns
Industry says waiver of IP rights not needed as vaccine supply far outweighs demand
Just half of 41 cancer drugs approved from 2017-2020 were available here at end of 2021
Medicines regularly not worth approving at asking price
Upfront costs high but treatments may cut long-term expense and boost patient results
Two Ministers back US support for patent waiver opposed by pharmaceutical industry
New medicines have cut number of years of life lost to heart disease by 34% since 2005
Major drug manufacturers already at full capacity producing other medications
Deal with pharma sector comes as talks on new drug pricing deal deferred until May
Study finds high proportion of people willing to get immunised against coronavirus
Optimists say July. Others September. We will return – gradually – to a much changed world
Pharma group says eight cancer therapies awaiting HSE approval for over 900 days
YOU MAY ALSO LIKE...
How does a post-Brexit world shape the identity and relationship of these islands
Inquests into the nightclub fire that led to the deaths of 48 people
Weddings, Births, Deaths and other family notices